Perthera Inc Press Releases

• Published on March 31, 2025 - 14:23 GMT

  New Perthera Peer-Reviewed Study Reveals Metastatic Site as Key Prognostic Factor in Pancreatic Cancer

  Findings published in The Oncologist underscore the need to account for metastatic site and genomic context in pancreatic cancer trial design MCCLEAN, VA, UNITED STATES, March 31, 2025 /⁨EINPresswire.com⁩/ -- In a significant advancement for pancreatic …

  Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...
• Published on February 26, 2025 - 14:00 GMT

  Perthera Report Pancreatic Version Now Available, Revolutionizing Chemo Selection for Pancreatic Cancer Treatment

  First-of-Its-Kind AI Predictor Eliminates Guesswork in Frontline Chemotherapy Selection, Empowering Oncologists with Unprecedented Data-Driven Insights MCCLEAN, VA, UNITED STATES, February 26, 2025 /⁨EINPresswire.com⁩/ -- Perthera, The Therapeutic …

  Distribution channels: Healthcare & Pharmaceuticals Industry, Insurance Industry ...
• Published on January 23, 2025 - 14:23 GMT

  Perthera to Present Research Validating World’s First AI-Driven Chemo Predictor at 2025 ASCO GI Cancers Symposium

  MCCLEAN, VA, UNITED STATES, January 23, 2025 /⁨EINPresswire.com⁩/ -- Perthera, a leader in precision oncology, will present follow-on research and validation of the world’s first AI-driven chemo predictor for frontline treatment in pancreatic cancer (PDAC) …

  Distribution channels: Healthcare & Pharmaceuticals Industry, IT Industry ...
• Published on January 14, 2025 - 17:26 GMT

  Perthera Announces Breakthrough in Pancreatic Cancer, World’s First AI-Driven Chemo Predictor for Frontline Treatment

  MCCLEAN, VA, UNITED STATES, January 14, 2025 /⁨EINPresswire.com⁩/ -- Perthera, a leader in AI-driven precision oncology, announces a groundbreaking advancement in the fight against pancreatic adenocarcinoma (PDAC) with the introduction of PDACai, the world …

  Distribution channels: Healthcare & Pharmaceuticals Industry, IT Industry ...
• Published on December 19, 2024 - 20:50 GMT

  Latest Perthera Report Further Advances AI-Powered Support for Personalized Cancer Therapies

  MCCLEAN, VA, UNITED STATES, December 19, 2024 /⁨EINPresswire.com⁩/ -- Perthera, a leader in AI-driven precision oncology, announces the release of version 4.0 of The Perthera Report®, an innovative decision-support tool that helps oncologists synthesize …

  Distribution channels: Healthcare & Pharmaceuticals Industry, Insurance Industry ...
• Published on December 16, 2024 - 20:39 GMT

  Perthera Finds Survival Differences in Lung vs. Liver Metastasis in New Study

  MCCLEAN, VA, UNITED STATES, December 16, 2024 /⁨EINPresswire.com⁩/ -- Perthera, the leader in AI-driven Precision Oncology Decision Support, has unveiled groundbreaking research on Pancreatic Ductal Adenocarcinoma (PDAC) that links survival outcomes to the …

  Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
• Published on November 25, 2024 - 21:25 GMT

  

  PERTHERA ANNOUNCES LANDMARK STUDY SHOWING MULTI-OMIC TESTING’S ROLE IN IMPROVING OUTCOMES FOR METASTATIC BREAST CANCER

  MCLEAN, VA, UNITED STATES, November 25, 2024 /⁨EINPresswire.com⁩/ -- Perthera, the industry leader in Precision Oncology Decision Support, in collaboration with researchers from George Mason University and The Side-Out Foundation, announces the publication …

  Distribution channels: Business & Economy, Companies ...
• Published on November 7, 2024 - 22:53 GMT

  

  Perthera, the Leading Therapeutic Intelligence Company, Releases vMTB 4.0, Accelerating AI Learning

  MCLEAN, VA, UNITED STATES, November 7, 2024 /⁨EINPresswire.com⁩/ -- Perthera, the industry leader in Precision Oncology Decision Support, announces the release of the latest version of its patented Virtual Molecular Tumor Board application, vMTB 4.0. The …

  Distribution channels: Business & Economy, Companies ...
• Published on July 10, 2024 - 14:00 GMT

  

  Perthera Names Marketing Veteran, Jeanne M. Cummins, Chief Marketing Officer (CMO)

  Appointment Drives Growth and Market Expansion with Strategic Leadership for Perthera, a Pioneer in Precision Oncology Decision Support MCLEAN, VA, UNITED STATES, July 10, 2024 /⁨EINPresswire.com⁩/ -- Perthera, The Therapeutic Intelligence Company® and …

  Distribution channels: Business & Economy, Companies ...
• Published on May 31, 2024 - 13:53 GMT

  

  At ASCO ’24, Perthera Launches New Services Aimed at Easing Burden on Clinicians Delivering Precision Oncology Care

  CHICAGO, IL, UNITED STATES, May 31, 2024 /⁨EINPresswire.com⁩/ -- Perthera has announced the addition of new services and capabilities to its Precision Oncology Platform suite aimed at making it easier for Oncologists to identify and deliver the best …

  Distribution channels: Business & Economy, Companies ...
• Published on April 24, 2024 - 16:26 GMT

  

  Renowned Oncologist and Cancer Researcher, Dr. Derek Raghavan, Joins Perthera as Chief Medical Officer

  MCLEAN, VA, UNITED STATES, April 24, 2024 /⁨EINPresswire.com⁩/ -- Perthera, the industry leader in Precision Oncology Decision Support announces that Dr. Derek Raghavan, MD, PhD, FACP, FRACP, FASCO, founding President of the Levine Cancer Institute and …

  Distribution channels: Business & Economy, Companies ...
• Published on April 2, 2024 - 19:24 GMT

  

  Perthera Names HealthTech and Medical Marketing Veteran, Donna Tuths, as CEO

  Appointment signals new phase of expansion for Perthera, a Pioneer in Precision Oncology Decision Support MCLEAN, VA, UNITED STATES, April 2, 2024 /⁨EINPresswire.com⁩/ -- Perthera, the industry leader in Precision Oncology Decision Support announces the …

  Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
• Published on January 18, 2024 - 20:44 GMT

  

  Precision Oncology Pioneer, Perthera, Presents Latest Research at ASCO GI 2024

  Perthera’s unique GI cancer-focused database helps identify new predictive signatures MCLEAN, VA, UNITED STATES, January 18, 2024 /⁨EINPresswire.com⁩/ -- Perthera, the industry leader in Precision Oncology Decision Support will be sharing its latest paper …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on February 8, 2023 - 01:27 GMT

  

  Perthera.ai Announces a Category III CPT Code from the AMA for Its Patented Precision Oncology Decision Support Platform

  The release of a Category III CPT code provides a critical pathway to reimbursement for Perthera’s AI-assisted decision support tool for oncologists. MCLEAN, VA, UNITED STATES, February 8, 2023 /⁨EINPresswire.com⁩/ -- Perthera.ai, the industry leader in …

  Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...